Buy or sell Membrion stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Membrion Stock

A Seattle, WA-based manufacturer of ultra-low cost, high performance ion exchange membranes.

About Membrion Stock

Membrion™ is a 2016 spin-out from the laboratories of the University of Washington (UW). Commercialization funding from the UW, the Murdock Charitable Trust, Amazon, the National Science Foundation (Award #1648517) and a consortium of California utilities (Rocket Fund) has helped to bridge the translation gap to a commercial product. In total, 11 different funding organizations have evaluated and financially supported Membrion's product development and commercialization plan. Most recently, that support has translated to private investment by angel investors as they scale their technology into commercial production.

Funding History

September 2018$748K
September 2018$1.0M
December 2018$485K
February 2019$3.1M

Management

CTO

Greg Newbloom

President & CEO

John Plaza

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Membrion or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 90K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo